• / Free eNewsletters & Magazine
  • / My Account
Home>NICE Issues Final Positive Recommendation for National Commissioning of Soliris® (eculizumab) for All Patients with aHUS in England

NICE Issues Final Positive Recommendation for National Commissioning of Soliris® (eculizumab) for All Patients with aHUS in England

3party Content

Thu, 27 Nov 2014

NICE Issues Final Positive Recommendation for National Commissioning of SolirisĀ® (eculizumab) for All Patients with aHUS in England
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.